BACH1 and hepatocellular carcinoma: To further verify the effects of these two inhibitors on the levels of BACH1, IGF1R and PTK2 in wild-type HCC cells, we treated the MHCC97H cells, which endogenously expressed BACH1, with either linsitinib alone or defactinib alone, or a combination of both (Figure S8).